http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102688194-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_550246a1a90f3c3034cf90d3392188d9
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 2012-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8a6ca0b38ee15a6d2c143f8caa077f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeacee05c9ae30f9b20493117e90e9c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_740253177d672abe8befc1d432b4f36d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40dabd579fc6f4879e34aea20205f90a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9db461ed29c800b583a019ac3a7b19d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be39b4919209a5dda693650d033e1fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bca08ba662f70d9f782448dfa852e5d3
publicationDate 2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102688194-B
titleOfInvention Preparation method of lidocaine ethosome
abstract The invention discloses a preparation method of lidocaine ethosome. The method comprises the steps of: uniformly mixing lecithin, lidocaine and ethanol solution, injecting PBS (Phosphate Buffer Solution), performing ultrasonic processing and filtering and the like. The method adopts a simple prescription and stable technological conditions, is easy to industrialize and has relatively great popularization values. The lidocaine ethosome prepared by the method is stable and has high entrapment efficiency, wherein the maximal entrapment efficiency of the optimized technology can reach 80.93%. The skin irritation test proves that the lidocaine ethosome has good affinity to the skin; the medicated part does not suffer the abnormal phenomena such as erythema, edema and the like; allergic reaction is avoided; and other physiological features are normal. Moreover, the lidocaine ethosome has a strong osmosis promoting effect, can obviously improve the medicine osmosis quantity of lidocaine, and is expected to be developed into novel efficient transdermal local anesthetics for external use.
priorityDate 2012-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452041512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457570881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409704282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449170258

Total number of triples: 33.